These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3369924)

  • 1. Oxidation of antipsoriatic 10-acyldithranol derivatives and dithranol to 1,8-dihydroxyanthraquinone.
    Taskinen J; Haarala J; Wartiovaara E; Halmekoski J
    Arch Pharm (Weinheim); 1988 Feb; 321(2):103-6. PubMed ID: 3369924
    [No Abstract]   [Full Text] [Related]  

  • 2. [10-Acyldithranol dimers; new derivatives of the antipsoriatic dithranol; synthesis, characterization and biochemical properties].
    Berset JD; Krebs A
    Pharm Acta Helv; 1990; 65(5-6):155-64. PubMed ID: 2371307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the stability of some antipsoriatic active anthralin (dithranol) derivatives.
    Schaltegger A; Bloch U; Krebs A
    Dermatologica; 1982 Oct; 165(4):363-8. PubMed ID: 7152072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Senecioyldithranol and beta-carbethoxypropionyldithranol: synthesis and glucose-6-phosphate dehydrogenase inhibition of two new 10-acyl derivatives of the antipsoriatic, dithranol].
    Rychener M; Steiger W; Krebs A
    Pharm Acta Helv; 1988; 63(4-5):111-6. PubMed ID: 3222264
    [No Abstract]   [Full Text] [Related]  

  • 5. Dithranol: further investigations on the structure-activity-relationship. The new series of the 10-mono-alkyldithranol derivatives.
    Schaltegger A; Brunner F; Steiger W; Krebs A
    Dermatologica; 1987; 175(3):136-41. PubMed ID: 3653461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and biochemical properties of new 10-acyl derivatives of dithranols: acetylsalicyldithranol and 1-acetyllactyldithranol].
    Berset JD; Krebs A
    Pharm Acta Helv; 1990; 65(1):14-9. PubMed ID: 2330383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthralin derivatives--inhibition of 5-lipoxygenase--antipsoriatic efficacy.
    Tanzer H; Braun C; Seidel M; Wiegrebe W
    Arch Pharm (Weinheim); 1991 Nov; 324(11):841-6. PubMed ID: 1804060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The oxidation behavior of dithranol].
    Schaltegger A
    Arzneimittelforschung; 1985; 35(4):666-8. PubMed ID: 4015731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
    Van Duuren BL; Segal A; Tseng SS; Rusch GM; Loewengart G; Maté U; Roth D; Smith A; Melchionne S; Seidman I
    J Med Chem; 1978 Jan; 21(1):26-31. PubMed ID: 619147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemical instability of the antipsoriatic dithranol and chrysarobin in aqueous systems: oxidation behavior].
    Berset JD; Krebs A
    Pharm Acta Helv; 1990; 65(3):66-9. PubMed ID: 2333308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
    Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
    J Invest Dermatol; 1986 Aug; 87(2):232-5. PubMed ID: 3016102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterocyclic substituted anthralin derivatives as inhibitors of keratinocyte growth and inducers of differentiation.
    Müller K; Reindl H; Breu K
    Bioorg Med Chem Lett; 2001 Jan; 11(1):47-50. PubMed ID: 11140730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of epidermal growth factor receptors by dithranol.
    Kemény L; Michel G; Arenberger P; Ruzicka T
    Acta Derm Venereol; 1993 Feb; 73(1):37-40. PubMed ID: 8095749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fumaryldithranol and sorbyldithranol: synthesis and glucose-6-phosphate-dehydrogenase antagonism in extended 10-acylation products in the antipsoriatic dithranol. 2].
    Rychener M; Steiger W; Krebs A
    Pharm Acta Helv; 1988; 63(12):322-6. PubMed ID: 3241812
    [No Abstract]   [Full Text] [Related]  

  • 18. Irritation, staining and antipsoriatic activity of 10-acyl analogues of anthralin.
    Mustakallio KK
    Br J Dermatol; 1981 Aug; 105 Suppl 20():23-7. PubMed ID: 6169361
    [No Abstract]   [Full Text] [Related]  

  • 19. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris.
    Kemény L; Ruzicka T; Braun-Falco O
    Skin Pharmacol; 1990; 3(1):1-20. PubMed ID: 2202336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active oxygen species and structure specificity of antipsoriatic anthrones.
    Müller K
    Arch Pharm (Weinheim); 1988 Jul; 321(7):385-9. PubMed ID: 3219054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.